Evaluation of alternative antibiotics for susceptibility of gonococcal isolates from China.

[1]  Louise J Jackson,et al.  Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial , 2019, The Lancet.

[2]  Q. Wang,et al.  Increasing prevalence of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone and resistance to azithromycin in Hangzhou, China (2015–17) , 2018, The Journal of antimicrobial chemotherapy.

[3]  Michael R. Wierzbicki,et al.  Single‐Dose Zoliflodacin (ETX0914) for Treatment of Urogenital Gonorrhea , 2018, New England Journal of Medicine.

[4]  M. Unemo,et al.  Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  Monica Lahra,et al.  Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin. , 2018, The Lancet. Infectious diseases.

[6]  A. Avery,et al.  Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation , 2018, Clinical Infectious Diseases.

[7]  Vikram Singh,et al.  In Vitro Synergy Testing of Gentamicin, an Old Drug Suggested as Future Treatment Option for Gonorrhoea, in Combination With Six Other Antimicrobials Against Multidrug-Resistant Neisseria gonorrhoeae Strains , 2018, Sexually transmitted diseases.

[8]  M. Ouellette,et al.  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. , 2017, The Lancet. Infectious diseases.

[9]  I. Martin,et al.  Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential , 2017, The Journal of antimicrobial chemotherapy.

[10]  E. André,et al.  Consensus numbering system for the rifampicin resistance-associated rpoB gene mutations in pathogenic mycobacteria. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  G. Domselaar,et al.  Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance, a Novel Antimicrobial Resistance Multilocus Typing Scheme for Tracking Global Dissemination of N. gonorrhoeae Strains , 2017, Journal of Clinical Microbiology.

[12]  D. Yong,et al.  In vitro activity of tigecycline alone and antimicrobial combinations against clinical Neisseria gonorrhoeae isolates. , 2017, Diagnostic microbiology and infectious disease.

[13]  J. Papp,et al.  Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016 , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Vikram Singh,et al.  Gentamicin Susceptibility among a Sample of Multidrug-Resistant Neisseria gonorrhoeae Isolates in India , 2016, Antimicrobial Agents and Chemotherapy.

[15]  S. van der Veen,et al.  High prevalence of Neisseria gonorrhoeae with high-level resistance to azithromycin in Hangzhou, China. , 2016, The Journal of antimicrobial chemotherapy.

[16]  M. Unemo,et al.  Gentamicin in vitro activity and tentative gentamicin interpretation criteria for the CLSI and calibrated dichotomous sensitivity disc diffusion methods for Neisseria gonorrhoeae. , 2016, The Journal of antimicrobial chemotherapy.

[17]  M. Unemo,et al.  Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea. , 2016, The New England journal of medicine.

[18]  Marleen Temmerman,et al.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting , 2015, PloS one.

[19]  Ulf Schaefer,et al.  An outbreak of high-level azithromycin resistant Neisseria gonorrhoeae in England , 2015, Sexually Transmitted Infections.

[20]  M. Golden,et al.  A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Christopher M. Bland,et al.  Neisseria gonorrhoeae and fosfomycin: Past, present and future. , 2015, International journal of antimicrobial agents.

[22]  A. V. van Dam,et al.  Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution. , 2015, International journal of antimicrobial agents.

[23]  H. Furrer,et al.  In Vitro Activity of Fosfomycin Alone and in Combination with Ceftriaxone or Azithromycin against Clinical Neisseria gonorrhoeae Isolates , 2014, Antimicrobial Agents and Chemotherapy.

[24]  J. Papp,et al.  The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  L. Duley,et al.  The effectiveness of gentamicin in the treatment of Neisseria gonorrhoeae: a systematic review , 2014, Systematic Reviews.

[26]  M. Unemo,et al.  Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future , 2014, Clinical Microbiology Reviews.

[27]  M. Cole,et al.  Evaluation of the activity of ertapenem against gonococcal isolates exhibiting a range of susceptibilities to cefixime. , 2014, The Journal of antimicrobial chemotherapy.

[28]  K. Holmes,et al.  In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae. , 2014, The Journal of antimicrobial chemotherapy.

[29]  D. Livermore,et al.  Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011. , 2013, The Lancet. Infectious diseases.

[30]  R. Kirkcaldy,et al.  Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis , 2012, Sexually Transmitted Infections.

[31]  M. Unemo,et al.  In Vitro Activity of Ertapenem versus Ceftriaxone against Neisseria gonorrhoeae Isolates with Highly Diverse Ceftriaxone MIC Values and Effects of Ceftriaxone Resistance Determinants: Ertapenem for Treatment of Gonorrhea? , 2012, Antimicrobial Agents and Chemotherapy.

[32]  M. Unemo,et al.  In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea? , 2012, Antimicrobial Agents and Chemotherapy.

[33]  M. Unemo,et al.  An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. , 2011, The Journal of antimicrobial chemotherapy.

[34]  F. Martinson,et al.  Neisseria gonorrhoeae Antimicrobial Susceptibility in Lilongwe, Malawi, 2007 , 2010, Sexually transmitted diseases.

[35]  C. Davies,et al.  High-Level Chromosomally Mediated Tetracycline Resistance in Neisseria gonorrhoeae Results from a Point Mutation in the rpsJ Gene Encoding Ribosomal Protein S10 in Combination with the mtrR and penB Resistance Determinants , 2005, Antimicrobial Agents and Chemotherapy.

[36]  D. Livermore,et al.  Activity of ertapenem against Neisseria gonorrhoeae. , 2004, The Journal of antimicrobial chemotherapy.

[37]  R. Jones,et al.  GAR-936 (9-t-butylglycylamido-minocycline) susceptibility test development for streptococci, Haemophilus influenzae and Neisseria gonorrhoeae: preliminary guidelines and interpretive criteria. , 2001, International journal of antimicrobial agents.

[38]  R. Jones,et al.  Anti-gonococcal activity of gemifloxacin against fluoroquinolone-resistant strains and a comparison of agar dilution and Etest methods. , 2000, The Journal of antimicrobial chemotherapy.

[39]  I. Hoffman,et al.  Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods , 1997, Journal of clinical microbiology.

[40]  E. P. van Steenbergen.  Treatment of gonorrhoea with single oral doses. Results obtained with doxycycline or rifampicin compared with intramuscular penicillin. , 1971, The British journal of venereal diseases.